Navigation Links
Ameritox Leadership Supports Lawmakers, Pain Practitioners and Patients Confronting Crisis in Pain Medication Abuse
Date:1/31/2013

BALTIMORE, Jan. 31, 2013 /PRNewswire/ -- Ameritox(SM), the nation's leader in Pain Medication Monitoring Solutions®, continues to address the prescription medication abuse crisis by educating lawmakers, physicians and chronic pain patients about the importance of ensuring that patients have access to needed medications, while keeping communities safe.

Chronic pain impacts one in four Americans – it affects more people than diabetes, cardiovascular disease, stroke and cancer combined – and is the most common cause of long-term disability in the United States.[1]  According to a 2011 Institute of Medicine report, chronic pain costs society at least $560-$635 billion annually.[2]  It is estimated that between four and eight million people suffering from chronic pain take opioid medications, prescribed by physicians to manage their condition and symptoms. 

"With prescription drug abuse rising to epidemic levels in the U.S., physicians treating chronic pain patients have a critical charge: to ensure their patients receive safe, effective treatment, while also reducing the possible risk of misuse, abuse or diversion of these powerful drugs," said Dr. Harry Leider , chief medical officer of Ameritox.  "For the millions of patients suffering from chronic pain, access to expert care and medication that can provide relief is crucial. It's important to ensure that policymakers, physicians and communities alike understand the magnitude of the problem and how to improve individual well-being and protect public safety."

Prescription pain medications are now misused and abused more frequently than illicit drugs like cocaine and heroin.  However, individuals abusing powerful prescription drugs are typically not patients prescribed these medicines.  Instead, teenagers, spouses and others in the home can take pills obtained through a family member's legitimate prescription. 

"In recent years, the number of deaths due to drug poisonings has been greater than those due to auto accidents," Dr. Leider said. "In short, it is now more dangerous to have medications unattended in your medicine cabinet than it is to get into a car." 

Dr. Leider shared this insight and others during a recent briefing on Capitol Hill regarding the need to provide chronic pain patients with effective treatments. The briefing was sponsored by the Coalition for Excellence in Medication Monitoring, of which Ameritox is a founding member. During his address to legislators and staffers from more than 33 House and Senate offices, Dr. Leider emphasized the value of using tools like pain medication monitoring which provide physicians with vital information necessary to make treatment decisions that can help keep patients safe.

Ameritox also supports recent expert Consensus Recommendations on the use and frequency of urine drug monitoring (UDM) for physicians treating chronic pain patients.  Published in July in the journal Pain Medicine, "Recommendations for Urine Drug Monitoring as a Component of Opioid Therapy in the Treatment of Chronic Pain" state that patients treated with opioids for more than three months should be tested routinely.  This is based on the fundamental principle that patients on chronic opioid treatments may have a significant degree of risk for misuse; and monitoring is necessary to help maintain patient safety and guide ongoing treatment decisions.

"At Ameritox, we're proud to advance the science of medication monitoring and UDM – and we also know that practical considerations and physician decisions are what drive progress in helping to protect patients," said Scott Walton , chief executive officer of Ameritox.  "We provide more than just laboratory services and technology – we are committed to helping physicians gain knowledge that will enable them to use that technology to provide the best possible care for patients."

About Urine Drug Monitoring
Urine drug monitoring, or UDM, allows physicians to monitor the presence of pain medication in a patient's system, helping them to ensure the patient receives adequate medication to provide relief, while also helping to prevent potential misuse, abuse or diversion of powerful narcotics.

About Ameritox
Ameritox is the nation's leader in Pain Medication Monitoring Solutions®, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers the most thorough pain medication monitoring lab process – Rx Guardian(SM) – with Rx Guardian CD(SM), the only pain medication monitoring process with a proprietary normalization algorithm and a reference database of pain patients clinically assessed for adherence. Patient results are compared against this database, helping physicians assess whether patients are taking their pain medications correctly. Monitoring through prescription drug testing helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter @Ameritox, on Facebook at facebook.com/ameritox, and on YouTube at www.youtube.com/ameritox.

© 2013 Ameritox Ltd. All rights reserved. Ameritox, Ameritox-Medication Monitoring Solutions, Rx Guardian, Rx Guardian INSIGHT and Rx Guardian CD are trademarks of Ameritox. Other trademarks are the property of their owners.

[1] American Pain Foundation. Facts about pain. Available at: http://www.painfoundation.org/page_fastfacts.asp. June 30, 2008.

[2] Institute of Medicine of the National Academies Report. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, 2011. The National Academies Press, Washington DC. (page 5)


'/>"/>
SOURCE Ameritox
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox and Wake Forest University Form Research Partnership
2. Ameritox Appoints New CEO, Scott Walton
3. Bath Salts: With Dangerous Drug Use on the Rise, Ameritox Launches Critical New Test to Help Detect Designer Drug
4. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
5. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
6. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
7. Sentrys Leadership in 340B Compliance Technology Featured at the Ninth Annual 340B Coalition Winter Conference
8. H. D. Smith Establishes Specialty Solutions Organization And Realigns Senior Leadership To Support Growing Geographic Reach, Diversified Businesses
9. Prescription Eyewear Limited Extends Clear Leadership Position in Growing European Online Optical Market With Acquisition of Nordic Leader LensOn
10. inVentiv Health Strengthens Clinical Leadership Team
11. Jardogs Strengthens Leadership Team with the Addition of Two Seasoned Healthcare Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):